91 related articles for article (PubMed ID: 35365302)
1. Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma.
Dong OM; Poonnen PJ; Winski D; Reed SD; Vashistha V; Bates J; Kelley MJ; Voora D
Value Health; 2022 Apr; 25(4):582-594. PubMed ID: 35365302
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
Suh JH; Johnson A; Albacker L; Wang K; Chmielecki J; Frampton G; Gay L; Elvin JA; Vergilio JA; Ali S; Miller VA; Stephens PJ; Ross JS
Oncologist; 2016 Jun; 21(6):684-91. PubMed ID: 27151654
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non-Small Cell Lung Cancer for the Colombian Health System.
Gamboa O; Bonilla CE; Quitian D; Torres GF; Buitrago G; Cardona AF
Value Health Reg Issues; 2024 Jan; 39():115-125. PubMed ID: 38101152
[TBL] [Abstract][Full Text] [Related]
4. Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non-Small-Cell Lung Cancer.
Yorio J; Lofgren KT; Lee JK; Tolba K; Oxnard GR; Schrock AB; Huang RSP; Brisbin L
JCO Precis Oncol; 2024 Mar; 8():e2300292. PubMed ID: 38452312
[TBL] [Abstract][Full Text] [Related]
5. ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.
Mersiades AJ; Solomon BJ; Thomas DM; Lee CK; Cummins MM; Sebastian L; Ballinger ML; Collignon E; Turnbull OM; Yip S; Morton RL; Brown C; Wheeler PJ; Itchins M; Simes RJ; Pavlakis N
Future Oncol; 2024 Mar; 20(7):361-371. PubMed ID: 37767626
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer.
Nesline MK; Subbiah V; Previs RA; Strickland KC; Ko H; DePietro P; Biorn MD; Cooper M; Wu N; Conroy J; Pabla S; Zhang S; Wallen ZD; Sathyan P; Saini K; Eisenberg M; Caveney B; Severson EA; Ramkissoon S
Oncol Ther; 2024 Mar; ():. PubMed ID: 38502426
[TBL] [Abstract][Full Text] [Related]
7. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer.
Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
[TBL] [Abstract][Full Text] [Related]
8. Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
Tomlins SA; Hovelson DH; Suga JM; Anderson DM; Koh HA; Dees EC; McNulty B; Burkard ME; Guarino M; Khatri J; Safa MM; Matrana MR; Yang ES; Menter AR; Parsons BM; Slim JN; Thompson MA; Hwang L; Edenfield WJ; Nair S; Onitilo A; Siegel R; Miller A; Wassenaar T; Irvin WJ; Schulz W; Padmanabhan A; Harish V; Gonzalez A; Mansoor AH; Kellum A; Harms P; Drewery S; Falkner J; Fischer A; Hipp J; Kwiatkowski K; Lazo de la Vega L; Mitchell K; Reeder T; Siddiqui J; Vakil H; Johnson DB; Rhodes DR
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476329
[TBL] [Abstract][Full Text] [Related]
9. Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice.
Singh AP; Shum E; Rajdev L; Cheng H; Goel S; Perez-Soler R; Halmos B
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375398
[TBL] [Abstract][Full Text] [Related]
10. An approach for improvement of the accuracy of cancer gene panel testing.
Imoto K; Yamamoto H; Ohkawa C; Shimada N; Ikuzawa R; Takeda H; Ohhara T; Kojima Y; Furuya N; Motoyoshi A; Migita O; Kuga A; Keira T; Wakamatsu H; Sato T; Oike N; Koike J; Yamano Y; Sunakawa Y
Int J Clin Oncol; 2024 May; 29(5):571-581. PubMed ID: 38472663
[TBL] [Abstract][Full Text] [Related]
11. The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology.
Kubo T; Sunami K; Koyama T; Kitami M; Fujiwara Y; Kondo S; Yonemori K; Noguchi E; Morizane C; Goto Y; Maejima A; Iwasa S; Hamaguchi T; Kawai A; Namikawa K; Arakawa A; Sugiyama M; Ohno M; Yoshida T; Hiraoka N; Yoshida A; Yoshida M; Nishino T; Furukawa E; Narushima D; Nagai M; Kato M; Ichikawa H; Fujiwara Y; Kohno T; Yamamoto N
ESMO Open; 2024 Apr; 9(4):102981. PubMed ID: 38613908
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan.
Yamaguchi T; Ikegami M; Aruga T; Kanemasa Y; Horiguchi SI; Kawai K; Takao M; Yamada T; Ishida H
Int J Clin Oncol; 2024 May; ():. PubMed ID: 38795236
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling in Predictive Testing of Cancer.
Svoboda M; Lohajova Behulova R; Slamka T; Sebest L; Repiska V
Physiol Res; 2023 Oct; 72(S3):S267-S275. PubMed ID: 37888970
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT).
Normanno N; Barberis M; De Marinis F; Gridelli C; On The Behalf Of The Aiot Expert Panel
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575424
[TBL] [Abstract][Full Text] [Related]
15. The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey.
Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M
Oncotarget; 2021 Oct; 12(21):2169-2176. PubMed ID: 34676049
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Multi-Cancer Genome Profiling: Data from a Single Hospital in Japan.
Aoyama R; Nishikubo H; Kawabata K; Kanei S; Yamamoto Y; Nishimura S; Yashiro M
Cancer Genomics Proteomics; 2024; 21(1):79-87. PubMed ID: 38151295
[TBL] [Abstract][Full Text] [Related]
17. Cell Painting predicts impact of lung cancer variants.
Caicedo JC; Arevalo J; Piccioni F; Bray MA; Hartland CL; Wu X; Brooks AN; Berger AH; Boehm JS; Carpenter AE; Singh S
Mol Biol Cell; 2022 May; 33(6):ar49. PubMed ID: 35353015
[TBL] [Abstract][Full Text] [Related]
18. Availability of genome-matched therapy based on clinical practice.
Hayashi N; Mori S; Ohmoto A; Fukada I; Yamazaki M; Hosonaga M; Wang X; Ueki A; Kiyotani K; Tonooka A; Takeuchi K; Takahashi S
Int J Clin Oncol; 2024 Apr; ():. PubMed ID: 38668785
[TBL] [Abstract][Full Text] [Related]
19. Molecular Signatures of Gynecological Cancers: Clinicians Perspective.
Shylasree TS; Richa B; Lavanya G; Gulia S
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):103-110. PubMed ID: 33994735
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling and metastatic risk in early-stage non-small cell lung cancer.
Fick CN; Dunne EG; Lankadasari MB; Mastrogiacomo B; Asao T; Vanstraelen S; Liu Y; Sanchez-Vega F; Jones DR
JTCVS Open; 2023 Dec; 16():9-16. PubMed ID: 38204702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
